Steven J. Metallo
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
73
Citations
3,084
Est. group size
—
Recurring co-author estimate
Active years
32
Publishing since 1994
Steven J. Metallo studies how small drug-like molecules can bind to intrinsically disordered proteins typically considered "undruggable" targets that lack fixed 3D shapes. A central focus is the MYC/MYCN family of transcription factors, which drive many cancers, and the design of small-molecule inhibitors that disrupt their activity.
Publication activity has been intermittent over the past decade with a pronounced spike in 2023 largely driven by supplementary materials from a single study, otherwise averaging a few outputs per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~7 · 5% small-team papers (≤3 authors) · across 6 venues
- Sensitivity of an early dark matter search using the electromagnetic calorimeter as a target for the Light Dark Matter eXperiment
Journal of High Energy Physics · 2025
- Data from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Methods, Legends for Figures 1-5 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 1 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 1 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Methods, Legends for Figures 1-5 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 3 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 5 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 2 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 2 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 3 from Improved low molecular weight Myc-Max inhibitors
2023
- Data from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 4 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 4 from Improved low molecular weight Myc-Max inhibitors
2023
- Supplementary Figure 5 from Improved low molecular weight Myc-Max inhibitors
2023
- Journal of Molecular Biology×1
- Cancer Research×1
- Methods in enzymology on CD-ROM/Methods in enzymology×1
- Journal of High Energy Physics×1
- Biomolecules×1
- Ryan L. Hayes
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jaie Woodard
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Chiwook Park
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Charles L. Brooks
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Chengxin Zhang
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile